A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer
Status:
RECRUITING
Trial end date:
2030-01-09
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out whether BMS986365 in combination with degarelix, given before standard surgical treatment (radical prostatectomy), is a safe and effective treatment that causes few or mild side effects for people who have localized high-risk prostate cancer.